Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation

Identifieur interne : 004E83 ( Main/Exploration ); précédent : 004E82; suivant : 004E84

In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation

Auteurs : Michael Maes [Thaïlande, Australie] ; Karl Ringel [Allemagne] ; Marta Kubera [Pologne] ; George Anderson [Royaume-Uni] ; Gerwyn Morris [Royaume-Uni] ; Piotr Galecki [Pologne] ; Michel Geffard [France]

Source :

RBID : Pascal:13-0302343

Descripteurs français

English descriptors

Abstract

Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is accompanied by activation of immuno-inflammatory pathways, increased bacterial translocation and autoimmune responses to serotonin (5-HT). Inflammation is known to damage 5-HT neurons while bacterial translocation may drive autoimmune responses. This study has been carried out to examine the autoimmune responses to 5-HT in ME/CFS in relation to inflammation and bacterial translocation. Methods: We examined 5-HT antibodies in 117 patients with ME/CFS (diagnosed according to the centers for disease control and prevention criteria, CDC) as compared with 43 patients suffering from chronic fatigue (CF) but not fulfilling the CDC criteria and 35 normal controls. Plasma interleukin-1 (IL-1), tumor necrosis factor (TNF)α, neopterin and the IgA responses to Gram-negative bacteria were measured. Severity of physio-somatic symptoms was measured using the fibromyalgia and chronic fatigue syndrome rating scale (FF scale). Results: The incidence of positive autoimmune activity against 5-HT was significantly higher (p < 0.001) in ME/CFS (61.5%) than in patients with CF (13.9%) and controls (5.7%). ME/CFS patients with 5-HT autoimmune activity displayed higher TNFα, IL-1 and neopterin and increased IgA responses against LPS of commensal bacteria than those without 5-HT autoimmune activity. Anti-5-HT antibody positivity was significantly associated with increased scores on hyperalgesia, fatigue, neurocognitive and autonomic symptoms, sadness and a flu-like malaise. Discussion: The results show that, in ME/CFS, increased 5-HT autoimmune activity is associated with activation of immuno-inflammatory pathways and increased bacterial translocation, factors which are known to play a role in the onset of autoimmune reactions. 5-HT autoimmune activity could play a role in the pathophysiology of ME/CFS and the onset of physio-somatic symptoms. These results provide mechanistic support for the notion that ME/CFS is a neuro-immune disorder.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation</title>
<author>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maes Clinics @ TRIA</s1>
<s2>Bangkok</s2>
<s3>THA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Thaïlande</country>
<wicri:noRegion>Maes Clinics @ TRIA</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Chulalongkorn University</s1>
<s2>Bangkok</s2>
<s3>THA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Thaïlande</country>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Psychiatry, Deakin University</s1>
<s2>Geelong, VIC</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Geelong, VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ringel, Karl" sort="Ringel, Karl" uniqKey="Ringel K" first="Karl" last="Ringel">Karl Ringel</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Immunologischen Laboratorien</s1>
<s2>Aachen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kubera, Marta" sort="Kubera, Marta" uniqKey="Kubera M" first="Marta" last="Kubera">Marta Kubera</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Experimental Endocrinology, Institute of Pharmacology, Polish Academy of Sciences</s1>
<s2>Krakow</s2>
<s3>POL</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
<wicri:noRegion>Krakow</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Anderson, George" sort="Anderson, George" uniqKey="Anderson G" first="George" last="Anderson">George Anderson</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>CRC, Rm 30</s1>
<s2>Glasgow, Scotland</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Glasgow, Scotland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Tir Na Nog, Pembrey</s1>
<s2>Llanelli</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Llanelli</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Galecki, Piotr" sort="Galecki, Piotr" uniqKey="Galecki P" first="Piotr" last="Galecki">Piotr Galecki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Department of Adult Psychiatry, Medical University of Lódź and Babinski Memorial Hospital</s1>
<s2>Lódź</s2>
<s3>POL</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
<wicri:noRegion>Lódź</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Geffard, Michel" sort="Geffard, Michel" uniqKey="Geffard M" first="Michel" last="Geffard">Michel Geffard</name>
<affiliation wicri:level="3">
<inist:fA14 i1="09">
<s1>Association Institute for Research & Development in Human Pathology and Therapy</s1>
<s2>Talence</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Talence</settlement>
<settlement type="city" wicri:auto="agglo">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">13-0302343</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0302343 INIST</idno>
<idno type="RBID">Pascal:13-0302343</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000825</idno>
<idno type="stanalyst">FRANCIS 13-0302343 INIST</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D95</idno>
<idno type="wicri:Area/PascalFrancis/Curation">005663</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000879</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000879</idno>
<idno type="wicri:doubleKey">0165-0327:2013:Maes M:in:myalgic:encephalomyelitis</idno>
<idno type="wicri:Area/Main/Merge">005053</idno>
<idno type="wicri:Area/Main/Curation">004E83</idno>
<idno type="wicri:Area/Main/Exploration">004E83</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation</title>
<author>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Maes Clinics @ TRIA</s1>
<s2>Bangkok</s2>
<s3>THA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Thaïlande</country>
<wicri:noRegion>Maes Clinics @ TRIA</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Psychiatry, Chulalongkorn University</s1>
<s2>Bangkok</s2>
<s3>THA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Thaïlande</country>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Psychiatry, Deakin University</s1>
<s2>Geelong, VIC</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Geelong, VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ringel, Karl" sort="Ringel, Karl" uniqKey="Ringel K" first="Karl" last="Ringel">Karl Ringel</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Immunologischen Laboratorien</s1>
<s2>Aachen</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kubera, Marta" sort="Kubera, Marta" uniqKey="Kubera M" first="Marta" last="Kubera">Marta Kubera</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Department of Experimental Endocrinology, Institute of Pharmacology, Polish Academy of Sciences</s1>
<s2>Krakow</s2>
<s3>POL</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
<wicri:noRegion>Krakow</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Anderson, George" sort="Anderson, George" uniqKey="Anderson G" first="George" last="Anderson">George Anderson</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>CRC, Rm 30</s1>
<s2>Glasgow, Scotland</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Glasgow, Scotland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Tir Na Nog, Pembrey</s1>
<s2>Llanelli</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Llanelli</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Galecki, Piotr" sort="Galecki, Piotr" uniqKey="Galecki P" first="Piotr" last="Galecki">Piotr Galecki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Department of Adult Psychiatry, Medical University of Lódź and Babinski Memorial Hospital</s1>
<s2>Lódź</s2>
<s3>POL</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
<wicri:noRegion>Lódź</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Geffard, Michel" sort="Geffard, Michel" uniqKey="Geffard M" first="Michel" last="Geffard">Michel Geffard</name>
<affiliation wicri:level="3">
<inist:fA14 i1="09">
<s1>Association Institute for Research & Development in Human Pathology and Therapy</s1>
<s2>Talence</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Talence</settlement>
<settlement type="city" wicri:auto="agglo">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of affective disorders</title>
<title level="j" type="abbreviated">J. affect. disord.</title>
<idno type="ISSN">0165-0327</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of affective disorders</title>
<title level="j" type="abbreviated">J. affect. disord.</title>
<idno type="ISSN">0165-0327</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Activity</term>
<term>Autoimmunity</term>
<term>Bacteriosis</term>
<term>Chronic fatigue syndrome</term>
<term>Cytokine</term>
<term>Depression</term>
<term>Encephalomyelitis</term>
<term>Inflammation</term>
<term>Serotonin</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Encéphalomyélite</term>
<term>Syndrome de fatigue chronique</term>
<term>Autoimmunité</term>
<term>Activité</term>
<term>Sérotonine</term>
<term>Inflammation</term>
<term>Bactériose</term>
<term>Cytokine</term>
<term>Etat dépressif</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is accompanied by activation of immuno-inflammatory pathways, increased bacterial translocation and autoimmune responses to serotonin (5-HT). Inflammation is known to damage 5-HT neurons while bacterial translocation may drive autoimmune responses. This study has been carried out to examine the autoimmune responses to 5-HT in ME/CFS in relation to inflammation and bacterial translocation. Methods: We examined 5-HT antibodies in 117 patients with ME/CFS (diagnosed according to the centers for disease control and prevention criteria, CDC) as compared with 43 patients suffering from chronic fatigue (CF) but not fulfilling the CDC criteria and 35 normal controls. Plasma interleukin-1 (IL-1), tumor necrosis factor (TNF)α, neopterin and the IgA responses to Gram-negative bacteria were measured. Severity of physio-somatic symptoms was measured using the fibromyalgia and chronic fatigue syndrome rating scale (FF scale). Results: The incidence of positive autoimmune activity against 5-HT was significantly higher (p < 0.001) in ME/CFS (61.5%) than in patients with CF (13.9%) and controls (5.7%). ME/CFS patients with 5-HT autoimmune activity displayed higher TNFα, IL-1 and neopterin and increased IgA responses against LPS of commensal bacteria than those without 5-HT autoimmune activity. Anti-5-HT antibody positivity was significantly associated with increased scores on hyperalgesia, fatigue, neurocognitive and autonomic symptoms, sadness and a flu-like malaise. Discussion: The results show that, in ME/CFS, increased 5-HT autoimmune activity is associated with activation of immuno-inflammatory pathways and increased bacterial translocation, factors which are known to play a role in the onset of autoimmune reactions. 5-HT autoimmune activity could play a role in the pathophysiology of ME/CFS and the onset of physio-somatic symptoms. These results provide mechanistic support for the notion that ME/CFS is a neuro-immune disorder.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Australie</li>
<li>France</li>
<li>Pologne</li>
<li>Royaume-Uni</li>
<li>Thaïlande</li>
</country>
<region>
<li>Aquitaine</li>
<li>Aquitaine-Limousin-Poitou-Charentes</li>
<li>District de Cologne</li>
<li>Rhénanie-du-Nord-Westphalie</li>
</region>
<settlement>
<li>Aix-la-Chapelle</li>
<li>Bordeaux</li>
<li>Talence</li>
</settlement>
</list>
<tree>
<country name="Thaïlande">
<noRegion>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</noRegion>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name>
</noRegion>
</country>
<country name="Allemagne">
<region name="Rhénanie-du-Nord-Westphalie">
<name sortKey="Ringel, Karl" sort="Ringel, Karl" uniqKey="Ringel K" first="Karl" last="Ringel">Karl Ringel</name>
</region>
</country>
<country name="Pologne">
<noRegion>
<name sortKey="Kubera, Marta" sort="Kubera, Marta" uniqKey="Kubera M" first="Marta" last="Kubera">Marta Kubera</name>
</noRegion>
<name sortKey="Galecki, Piotr" sort="Galecki, Piotr" uniqKey="Galecki P" first="Piotr" last="Galecki">Piotr Galecki</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Anderson, George" sort="Anderson, George" uniqKey="Anderson G" first="George" last="Anderson">George Anderson</name>
</noRegion>
<name sortKey="Morris, Gerwyn" sort="Morris, Gerwyn" uniqKey="Morris G" first="Gerwyn" last="Morris">Gerwyn Morris</name>
</country>
<country name="France">
<region name="Aquitaine-Limousin-Poitou-Charentes">
<name sortKey="Geffard, Michel" sort="Geffard, Michel" uniqKey="Geffard M" first="Michel" last="Geffard">Michel Geffard</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E83 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E83 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:13-0302343
   |texte=   In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024